文献速递主动脉疾病

Endurant支架在挑战性腹主动脉瘤解剖中5年结果良好

Endurant stent graft demonstrates promising outcomes in challenging abdominal aortic aneurysm anatomy.
PubMed 文献 · J Vasc Surg · 2020-05-19

基于ENGAGE注册研究,评估Endurant支架超适应证使用(225例,17.8%)与适应证内使用(1038例,82.2%)患者的5年安全性和有效性。超适应证组女性比例更高(19.1% vs 8.7%,P < .001),5年免于IA型内漏率较低(89.4% vs 96.7%,P < .0001),但全因死亡、动脉瘤相关死亡和二次手术无差异。

要点

  • 超适应证使用常见原因为近端瘤颈成角或直径超出IFU。
  • 超适应证组5年免于IA型内漏率显著低于适应证内组。
  • 两组5年全因死亡、动脉瘤相关死亡和二次手术无差异。

核心结论

  • Endurant支架在超适应证腹主动脉瘤解剖中5年结果良好,全因死亡和动脉瘤相关死亡与适应证内使用无差异。
  • 超适应证使用增加IA型内漏发生率,但免于二次手术率无显著差异。

研究设计与样本

  • ENGAGE为全球上市后注册研究,纳入接受Endurant支架治疗的腹主动脉瘤患者。
  • 超适应证组225例(17.8%),适应证内组1038例(82.2%),随访5年。

主要发现

  • 超适应证组女性比例更高(19.1% vs 8.7%,P < .001),冠心病和血运重建率更低,症状性患者更多(21.3% vs 15.0%,P = .020)。
  • 技术成功率两组均超过99%,术后即刻未纠正I型(0.9% vs 1.2%,P = 1.00)和III型内漏(0.4% vs 0.3%,P = .54)发生率低且相当。
  • 5年免于IA型内漏率超适应证组低于适应证内组(89.4% vs 96.7%,P < .0001),III型内漏无差异(P = .61)。
  • 5年需I型或III型内漏纠正手术的趋势超适应证组略高(7.2% vs 5.2%,P = .099)。
  • 两组5年全因死亡、动脉瘤相关死亡和二次手术无差异。

关键数值与推荐

  • 超适应证定义:超出Endurant支架获批适应证,最常见原因为近端瘤颈成角或直径超出IFU。
  • 主要终点12个月治疗成功定义:成功输送和释放支架,无I型或III型内漏、支架移位或分支闭塞、晚期转换、动脉瘤直径增大或破裂。

临床怎么用

  • 在超适应证解剖中,Endurant支架仍可考虑使用,但需警惕IA型内漏风险增加。
  • 超适应证患者术后应加强IA型内漏监测,尤其近端瘤颈成角或直径超限者。

局限性

  • 注册研究非随机对照,可能存在选择偏倚。
  • 超适应证组样本量较小(225例),事件数有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to assess the 5-year safety and effectiveness outcomes of patients enrolled in the Endurant Stent Graft Natural Selection Global Post Market Registry (ENGAGE) who were treated outside the approved indications for use (IFU) of the Endurant stent graft. METHODS: Our primary outcome measure was 12-month treatment success, defined as successful endograft delivery and deployment and the absence of type I or III endoleak, stent migration or limb occlusion, late conversion, and abdominal aortic aneurysm diameter increase or rupture. Secondary outcome measures included 30-day all-cause mortality, major adverse events, secondary procedures, technical observations, aneurysm-related mortality, and all-cause mortality within 12 months. RESULTS: Demographic characteristics of ENGAGE patients treated outside (225 [17.8%]) and within (1038 [82.2%]) the IFUs were similar, except that female patients comprised a much higher percentage of the outside IFU group (19.1% vs 8.7%; P < .001). The outside IFU group presented with lower rates of coronary artery disease and cardiac revascularization and a greater number of symptomatic patients compared with the within IFU group (21.3% vs 15.0%; P = .020). Technical success was achieved in more than 99% of all patients. The outside and within IFU groups showed a comparable and low occurrence of uncorrected type I (0.9% vs 1.2%; P = 1.00) and type III endoleak (0.4% vs 0.3%; P = .54) immediately after device implantation. The 5-year freedom from type IA endoleaks was 89.4% vs 96.7% (P < .0001) for those patients outside and within the IFUs, respectively, although both groups had similar type III endoleaks through 5 years (P = .61). Stent graft limb occlusion estimated overall survival, and freedom from aneurysm-related mortality and endovascular interventions were comparable in both patient groups through the 5-year follow-up. The Kaplan-Meier estimates at 5 years showed a trend for low but increased need for type I or III endoleak correction procedures in the outside IFU group compared with the within IFU group (7.2% vs 5.2%; P = .099). CONCLUSIONS: Differences were not observed in all-cause mortality, aneurysm-related mortality, and secondary procedures between within and outside IFU patients through a 5-year follow-up in the ENGAGE registry. Proximal necks with angulation or diameters outside the IFUs were the most common reasons for patients identified as being outside IFU, and the cohort had increased incidence of type IA endoleaks. Despite the challenges presented from the broad range of aortic and abdominal aortic aneurysm morphologies, the Endurant stent graft showed promising 5-year outcomes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Mwipatayi BP, Faraj J, Oshin O, et al. Endurant stent graft demonstrates promising outcomes in challenging abdominal aortic aneurysm anatomy. J Vasc Surg. 2020. PMID: 32442605. doi:10.1016/j.jvs.2020.04.508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。